Compare $DRMA vs $VRCI.L | Chartloom

Compare

$DRMA vs $VRCI.L

DRMA

Dermata Therapeutics Inc

VRCI.L

Error

Compare $DRMA vs $VRCI.L

DRMADermata Therapeutics Inc

VRCI.L

Error

DRMADermata Therapeutics Inc

Market cap

$4M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

11.49x

Rev growth (TTM)

—

YTD performance

-53.2%

52W performance

-78.7%

FCF yield

-198.6%

VRCI.L

Market cap

—

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

—

52W performance

—

FCF yield

—

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DRMA

VRCI.L

Not enough overlapping price history for this window.

Detailed metrics comparison

DRMA

Dermata Therapeutics Inc

VRCI.L

Market Cap

DRMA$4M

VRCI.L

Enterprise Value

DRMA$-312K

VRCI.L

Price

DRMA$1.02

VRCI.L

P/E Ratio

DRMAN/A

VRCI.L

P/S Ratio

DRMA0.00x

VRCI.L

EV/Sales

DRMA0.00x

VRCI.L

EV/EBITDA

DRMA0.00x

VRCI.L

P/B Ratio

DRMA1.27x

VRCI.L

P/FCF Ratio

DRMAN/A

VRCI.L

EV/FCF

DRMA0.04x

VRCI.L

PEG Ratio

DRMAN/A

VRCI.L

Forward P/E (NTM)

DRMAN/A

VRCI.L

Forward P/S (NTM)

DRMA11.49x

VRCI.L

Revenue (TTM)

DRMA$0

VRCI.L

Revenue Growth (YoY)

DRMAN/A

VRCI.L

Forward Rev Growth

DRMA650.0%

VRCI.L

Gross Margin (TTM)

DRMA0.0%

VRCI.L

Operating Margin (TTM)

DRMA0.0%

VRCI.L

EBITDA Margin (TTM)

DRMA0.0%

VRCI.L

Net Margin (TTM)

DRMA0.0%

VRCI.L

FCF Margin (TTM)

DRMAN/A

VRCI.L

Net Income (TTM)

DRMA$-8M

VRCI.L

FCF (TTM)

DRMA$-8M

VRCI.L

EPS (TTM)

DRMA-$2.08

VRCI.L

ROE (TTM)

DRMA-16667.0%

VRCI.L

ROA (TTM)

DRMA-13014.0%

VRCI.L

ROIC (TTM)

DRMA-16667.0%

VRCI.L

Cash

DRMA$4M

VRCI.L

Debt

DRMA$0

VRCI.L

Net Cash/Debt

DRMA$4M

VRCI.L

Current Ratio (TTM)

DRMA2.81x

VRCI.L

Quick Ratio (TTM)

DRMA2.62x

VRCI.L

Debt/Equity (TTM)

DRMA0.00x

VRCI.L

Debt/Assets (TTM)

DRMA0.0%

VRCI.L

Interest Coverage (TTM)

DRMAN/A

VRCI.L

Net Debt/EBITDA (TTM)

DRMA0.00x

VRCI.L

Beta

DRMA0.58

VRCI.L

52W Performance

DRMA-78.7%

VRCI.L

YTD Performance

DRMA-53.2%

VRCI.L

% from 52W High

DRMA-78.9%

VRCI.L

% from 52W Low

DRMA7.3%

VRCI.L

Asset Turnover (TTM)

DRMA0.00x

VRCI.L

FCF Yield (TTM)

DRMA-198.6%

VRCI.L

Earnings Yield (TTM)

DRMA-204.1%

VRCI.L

Dividend Yield (TTM)

DRMAN/A

VRCI.L

Rule of 40

DRMA0.0

VRCI.L

EV/GP/RG

DRMAN/A

VRCI.L

Ticker research

View DRMA research View VRCI.L research

Metric	DRMA Dermata Therapeutics Inc	VRCI.L
Market & Valuation
Market Cap	$4M
Enterprise Value	$-312K
Price	$1.02
P/E Ratio	N/A
P/S Ratio	0.00x
EV/Sales	0.00x
EV/EBITDA	0.00x
P/B Ratio	1.27x
P/FCF Ratio	N/A
EV/FCF	0.04x
PEG Ratio	N/A
Forward P/E (NTM)	N/A
Forward P/S (NTM)	11.49x
Revenue & Growth
Revenue (TTM)	$0
Revenue Growth (YoY)	N/A
Forward Rev Growth	650.0%
Profitability
Gross Margin (TTM)	0.0%
Operating Margin (TTM)	0.0%
EBITDA Margin (TTM)	0.0%
Net Margin (TTM)	0.0%
FCF Margin (TTM)	N/A
Net Income (TTM)	$-8M
FCF (TTM)	$-8M
EPS (TTM)	-$2.08
ROE (TTM)	-16667.0%
ROA (TTM)	-13014.0%
ROIC (TTM)	-16667.0%
Financial Health
Cash	$4M
Debt	$0
Net Cash/Debt	$4M
Current Ratio (TTM)	2.81x
Quick Ratio (TTM)	2.62x
Debt/Equity (TTM)	0.00x
Debt/Assets (TTM)	0.0%
Interest Coverage (TTM)	N/A
Net Debt/EBITDA (TTM)	0.00x
Performance
Beta	0.58
52W Performance	-78.7%
YTD Performance	-53.2%
% from 52W High	-78.9%
% from 52W Low	7.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x
FCF Yield (TTM)	-198.6%
Earnings Yield (TTM)	-204.1%
Dividend Yield (TTM)	N/A
Other
Rule of 40	0.0
EV/GP/RG	N/A
Ticker research	View DRMA research	View VRCI.L research

Valuation

Growth & revenue

Profitability & performance

Detailed metrics comparison

DRMA

Dermata Therapeutics Inc

VRCI.L

Market Cap

DRMA$4M

VRCI.L

Enterprise Value

DRMA$-312K

VRCI.L

Price

DRMA$1.02

VRCI.L

P/E Ratio

DRMAN/A

VRCI.L

P/S Ratio

DRMA0.00x

VRCI.L

EV/Sales

DRMA0.00x

VRCI.L

EV/EBITDA

DRMA0.00x

VRCI.L

P/B Ratio

DRMA1.27x

VRCI.L

P/FCF Ratio

DRMAN/A

VRCI.L

EV/FCF

DRMA0.04x

VRCI.L

PEG Ratio

DRMAN/A

VRCI.L

Forward P/E (NTM)

DRMAN/A

VRCI.L

Forward P/S (NTM)

DRMA11.49x

VRCI.L

Revenue (TTM)

DRMA$0

VRCI.L

Revenue Growth (YoY)

DRMAN/A

VRCI.L

Forward Rev Growth

DRMA650.0%

VRCI.L

Gross Margin (TTM)

DRMA0.0%

VRCI.L

Operating Margin (TTM)

DRMA0.0%

VRCI.L

EBITDA Margin (TTM)

DRMA0.0%

VRCI.L

Net Margin (TTM)

DRMA0.0%

VRCI.L

FCF Margin (TTM)

DRMAN/A

VRCI.L

Net Income (TTM)

DRMA$-8M

VRCI.L

FCF (TTM)

DRMA$-8M

VRCI.L

EPS (TTM)

DRMA-$2.08

VRCI.L

ROE (TTM)

DRMA-16667.0%

VRCI.L

ROA (TTM)

DRMA-13014.0%

VRCI.L

ROIC (TTM)

DRMA-16667.0%

VRCI.L

Cash

DRMA$4M

VRCI.L

Debt

DRMA$0

VRCI.L

Net Cash/Debt

DRMA$4M

VRCI.L

Current Ratio (TTM)

DRMA2.81x

VRCI.L

Quick Ratio (TTM)

DRMA2.62x

VRCI.L

Debt/Equity (TTM)

DRMA0.00x

VRCI.L

Debt/Assets (TTM)

DRMA0.0%

VRCI.L

Interest Coverage (TTM)

DRMAN/A

VRCI.L

Net Debt/EBITDA (TTM)

DRMA0.00x

VRCI.L

Beta

DRMA0.58

VRCI.L

52W Performance

DRMA-78.7%

VRCI.L

YTD Performance

DRMA-53.2%

VRCI.L

% from 52W High

DRMA-78.9%

VRCI.L

% from 52W Low

DRMA7.3%

VRCI.L

Asset Turnover (TTM)

DRMA0.00x

VRCI.L

FCF Yield (TTM)

DRMA-198.6%

VRCI.L

Earnings Yield (TTM)

DRMA-204.1%

VRCI.L

Dividend Yield (TTM)

DRMAN/A

VRCI.L

Rule of 40

DRMA0.0

VRCI.L

EV/GP/RG

DRMAN/A

VRCI.L

Ticker research

View DRMA research View VRCI.L research

Metric	DRMA Dermata Therapeutics Inc	VRCI.L
Market & Valuation
Market Cap	$4M
Enterprise Value	$-312K
Price	$1.02
P/E Ratio	N/A
P/S Ratio	0.00x
EV/Sales	0.00x
EV/EBITDA	0.00x
P/B Ratio	1.27x
P/FCF Ratio	N/A
EV/FCF	0.04x
PEG Ratio	N/A
Forward P/E (NTM)	N/A
Forward P/S (NTM)	11.49x
Revenue & Growth
Revenue (TTM)	$0
Revenue Growth (YoY)	N/A
Forward Rev Growth	650.0%
Profitability
Gross Margin (TTM)	0.0%
Operating Margin (TTM)	0.0%
EBITDA Margin (TTM)	0.0%
Net Margin (TTM)	0.0%
FCF Margin (TTM)	N/A
Net Income (TTM)	$-8M
FCF (TTM)	$-8M
EPS (TTM)	-$2.08
ROE (TTM)	-16667.0%
ROA (TTM)	-13014.0%
ROIC (TTM)	-16667.0%
Financial Health
Cash	$4M
Debt	$0
Net Cash/Debt	$4M
Current Ratio (TTM)	2.81x
Quick Ratio (TTM)	2.62x
Debt/Equity (TTM)	0.00x
Debt/Assets (TTM)	0.0%
Interest Coverage (TTM)	N/A
Net Debt/EBITDA (TTM)	0.00x
Performance
Beta	0.58
52W Performance	-78.7%
YTD Performance	-53.2%
% from 52W High	-78.9%
% from 52W Low	7.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x
FCF Yield (TTM)	-198.6%
Earnings Yield (TTM)	-204.1%
Dividend Yield (TTM)	N/A
Other
Rule of 40	0.0
EV/GP/RG	N/A
Ticker research	View DRMA research	View VRCI.L research